The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

22 Apr 2021 12:00

RNS Number : 3335W
Dignity PLC
22 April 2021
 

Dignity plc

Results of Resolutions considered at General Meeting

Dignity plc (the "Company") announces that at the general meeting of shareholders held earlier today, both of the resolutions proposed by Phoenix UK Fund Limited ("Phoenix"), the Company's largest shareholder (currently holding approximately 29.9% of the Company's voting share capital) were passed. The voting was conducted on a poll, with all valid proxy votes being cast by the chairman of the meeting.

The voting on each resolution was as follows:-

· Resolution 1 - To remove Clive Whiley as a director of the Company.

· 24,206,179 shares (approximately 55%) were voted FOR this resolution.

· 20,114,682 shares (approximately 45%) were voted AGAINST this resolution.

 

· Resolution 2 - To appoint Gary Channon as an executive director of the Company

· 26,799,557 shares (approximately 61%) were voted FOR this resolution

· 17,521,304 shares (approximately 39%) were voted AGAINST this resolution.

Votes on both resolutions were cast in respect of approximately 88% of the company's issued share capital. Excluding the votes cast on the resolutions by Phoenix, the views expressed by other shareholders were substantially in support of the independent directors' recommendation to vote against the resolutions.

At the meeting, the acting chairman, Dean Moore, made the following statement:-

"At the request of a number of the company's larger shareholders, since this shareholder meeting was convened, the independent directors have held substantive discussions with both Phoenix and Clive Whiley in order to try and find a mutually acceptable solution which would allow the Company to benefit from the continued involvement of both Clive Whiley and Gary Channon (as a representative of the Company's largest shareholder) in developing the Company's strategy for the consideration of all shareholders. A proposal was put to Phoenix whereby Clive Whiley would continue as Chairman, but in a non-executive capacity, with Gary Channon being appointed as interim chief executive officer until a more permanent appointment can be made. In spite of the best efforts of the independent directors and the willingness of Clive Whiley to proceed in this manner, unfortunately it has not been possible to reach such a compromise."

As a result of these developments, Clive Whiley has ceased to be a director of the Company and Gary Channon has been appointed as an executive director, in each case with immediate effect.

In addition (and as foreshadowed in the Company's circular to shareholders dated 29 March 2021), each of the independent directors, being Gillian Kent, Dean Moore and Paul Humphreys believe their positions as directors as a result of the resolutions being passed will be seriously compromised. Gillian Kent and Paul Humphreys have reluctantly concluded that they would be unable properly to perform their duties as directors on the reconstituted board. They have accordingly tendered their respective resignations from the board with immediate effect. Dean Moore has also tendered his resignation, although given his position as interim executive finance director, he has expressed his willingness to serve his three months' notice period should the newly constituted board request this.

The newly reconstituted board comprises Gary Channon, James Wilson and Andrew Judd and it will be for that board to determine respective roles and duties.

A further announcement will be made in due course.

Tim George

Company Secretary

22nd April 2021

 

For further information please contact:

 Richard Oldworth

Chris Lane

Tilly Abraham

Buchanan +44 (0)20 7466 5000

www.buchanan.uk.com Dignity@buchanan.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBGGDSIUDDGBD
Date   Source Headline
17th Oct 202211:05 amRNSNotification of Major Holdings
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results
29th Sep 202211:31 amRNSResults of Consent Solicitation with Bondholders
15th Sep 20228:37 amRNSChange in Director’s Particulars
15th Sep 20227:00 amRNSUpdate to release date of 2022 Half-Year Results
7th Sep 20223:55 pmRNSConsent solicitation with Noteholders
31st Aug 20228:55 amRNSVoting Rights and Capital
29th Jul 202210:01 amRNSVoting Rights and Capital
29th Jul 20227:46 amRNSFCA Regulation
20th Jul 20229:00 amRNSDignity Announces Aim to be Net Zero By 2038
30th Jun 20224:50 pmRNSVoting Rights and Capital
17th Jun 20227:25 amRNS“intending to authorise” status from the FCA
14th Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jun 20223:12 pmRNSBoard Update
9th Jun 202212:54 pmRNSResults of AGM
6th Jun 20227:00 amRNSNotification of Major Holdings
31st May 20227:00 amRNSVoting Rights and Capital
27th May 20222:52 pmRNSChange in Director’s Particulars
16th May 20227:00 amRNSAppointment of Chief Executive Officer
11th May 20227:00 amRNSFirst Quarter Trading Update
3rd May 202210:41 amRNSNotification of Major Holdings
29th Apr 20228:04 amRNS2021 Annual Report & Notice of 2022 AGM
29th Apr 20227:00 amRNSVoting Rights and Capital
14th Apr 202210:24 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th Apr 202210:59 amRNSDirectorate Change
31st Mar 20227:00 amRNSTotal Voting Rights
30th Mar 202212:34 pmRNSNotification of Major Holdings
23rd Mar 20227:00 amRNSPreliminary Results
11th Mar 202211:49 amRNSResults of Bondholders Consent Solicitation
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSVoting Rights and Capital
17th Feb 202210:30 amRNSTrading Update & Consent solicitation period
14th Feb 20227:00 amRNSNotification of Preliminary Results
12th Jan 202212:57 pmRNSBoard Appointment
7th Jan 20223:30 pmRNSBoard Appointments
31st Dec 20217:00 amRNSVoting Rights and Capital
17th Dec 20218:49 amRNSDirector Dealing Notification
14th Dec 202110:16 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSVoting Rights and Capital
8th Nov 20217:00 amRNSQ3 Trading Update
21st Oct 20217:00 amRNSAppointment of Joint Broker
14th Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20217:00 amRNSVoting Rights and Capital
21st Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSBoard Appointment
26th Jul 20217:00 amRNSBoard Appointment
12th Jul 20217:00 amRNSUpdate to release date of 2021 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.